Cerebrolysin protects PC12 cells from CoCl2-induced hypoxia employing GSK3β signaling

International Journal of Developmental Neuroscience

Volumn 38, Issue , 2014, Pages 52-58

  Hartwig, Kerstin ^b   Fackler, Viktoria ^b   Jaksch Bogensperger, Heidi ^a   Winter, Stefan ^b   Furtner, Tanja ^a   Couillard Despres, Sebastien ^a   Meier, Dieter ^b   Moessler, Herbert ^b   Aigner, Ludwig ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b EVER Neuro Pharma GmbH   (Austria)

Author keywords

Cell death; Neuroprotection; Neurotrophic factors

Indexed keywords

CASPASE 3; CASPASE 7; CEREBROLYSIN; COBALT CHLORIDE; GLYCOGEN SYNTHASE KINASE 3BETA; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; AMYLOID BETA PROTEIN; NERVE GROWTH FACTOR; PEPTIDE; PRIONEX; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXPOSURE; FLUORESCENCE ACTIVATED CELL SORTING; IN VITRO STUDY; NERVE CELL; NEUROPROTECTION; NONHUMAN; PC12 CELL LINE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ALZHEIMER DISEASE; APOPTOSIS; CELL PROTECTION; CELL STRESS; CELL VOLUME; NEUROTOXICITY;

EID: 84906658638     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2014.07.005     Document Type: Article

References (47)

1. Alvarez X.A., Cacabelos R., Laredo M., Couceiro V., Sampedro C., Varela M., Corzo L., Fernandez-Novoa L., Vargas M., Aleixandre M., Linares C., Granizo E., Muresanu D., Moessler H. A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease. Eur. J. Neurol. 2006, 13:43-54.
2. Alvarez X.A., Cacabelos R., Sampedro C., Aleixandre M., Linares C., Granizo E., Doppler E., Moessler H. Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer's disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin. Eur. J. Neurol. 2011, 18:59-68.
3. Chandel N.S., Maltepe E., Goldwasser E., Mathieu C.E., Simon M.C., Schumacker P.T. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. PNAS 1998, 95:11715-11720.
4. Cohen S. Purification of a nerve growth factor promoting protein from a mouse salivary gland and its neurocytoxic antiserum. PNAS 1960, 46:302-311.
5. Cole A.R. GSK3 as a sensor determining cell fate in the brain. Front. Mol. Neurosci. 2012, 5:4. 10.3389/fnmol.2012.00004.eCollection.
6. Das K.P., Freudenrich T.M., Mundy W.R. Assessment of PC12 cell differentation and neurite growth: a comparison of morphological and neurochemical measures. Neurotoxicol. Teratol. 2004, 26:397-406.
7. ® - Solution for Injection: Summary of Product Characteristics 2009.
8. Ekshyyan O., Aw T.Y. Decreased susceptibility of differentiated PC12 cells to oxidative challenge: relationship to cellular redox and expression of apoptotic protease activator factor-1. Cell Death Differ. 2005, 12:1066-1077.
9. Fang X., Yu S.X., Lu Y., Bast R.C., Woodgett J.R., Mills G.B. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. PNAS 2000, 97:11960-11965.
10. Fernando P., Brunette S., Megeney L.A. Neural stem cell differentiation is dependent upon endogenous caspase-3 activity. FASEB J. 2005, 19:1671-1673.
11. Flugel D., Gorlach A., Michiels C., Kietzmann T. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Mol. Cell. Biol. 2007, 27:3253-3265.
12. Francis-Turner L., Valouskova V., Mokry J. The long-term effect of NGF, b-FGF and Cerebrolysin on the spatial memory after fimbria-fornix lesion in rats. J. Neural Transm. Suppl. 1996, 47:277.
13. Francis-Turner L., Valouskova V. Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study. Neurosci. Lett. 1996, 202:193-196.
14. Greene L.A. Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J. Cell Biol. 1978, 78:747-755.
15. Gutmann B., Hutter-Paier B., Skofitsch G., Windisch M., Gmeinbauer R. In vitro models of brain ischemia: the peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death. Neurotox. Res. 2002, 4:59-65.
16. Hartbauer M., Hutter-Paier B., Skofitsch G., Windisch M. Antiapoptotic effects of the peptidergic drug cerebrolysin on primary cultures of embryonic chick cortical neurons. J. Neural Transm. 2001, 108:459-473.
17. Hutter-Paier B., Grygar E., Windisch M. Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative Cerebrolysin. J. Neural Transm. Suppl. 1996, 47:267-273.
18. 2-induced apoptosis of rat PC12 cells. Neurosci. Lett. 2004, 371:85-90.
19. Ke Q., Costa M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 2006, 70:1469-1480.
20. 2S against chemical hypoxia-induced inflammation in PC12 cells. Neurochem. Res. 2013, 38:1454-1466.
21. Lindsay R.M., Thoenen H., Barde Y.A. Placode and neural crest-derived sensory neurons are responsive at early developmental stages to brain-derived neurotrophic factor. Dev. Biol. 1985, 112:319-328.
22. Linford N.J., Dorsa D.M. 17beta-estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 2002, 67:1029-1040.
23. Loberg R.D., Vesely E., Brosius F.C. Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism. J. Biol. Chem. 2002, 277:41667-41673.
24. Longo F.M., Massa S.M. Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease. Nat. Rev. Drug Discov. 2013, 12:507-525.
25. Mallory M., Honer W., Hsu L., Johnson R., Rockenstein E., Masliah E. In vitro synaptotrophic effects of Cerebrolysin in NT2N cells. Acta Neuropathol. 1999, 97:437-446.
26. Masliah E., Armasolo F., Veinbergs I., Mallory M., Samuel W. Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice. Pharmacol. Biochem. Behav. 1999, 62:239-245.
27. Masliah E., Diez-Tejedor E. The pharmacology of neurotrophic treatment with Cerebrolysin: brain protection and repair to counteract pathologies of acute and chronic neurological disorders. Drugs Today 2012, 48(Suppl. A):3-24. 10.1358/dot.2012.48(Suppl.A).1739716.
28. Mottet D., Dumont V., Deccache Y., Demazy C., Ninane N., Raes M., Michiels C. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxicconditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3betapathway in HepG2 cells. J. Biol. Chem. 2003, 278:31277-31285.
29. Piswanger A., Paier B., Windisch M. Modulation of protein synthesis in cell-free system from rat brain by Cerebrolysin during development and aging. Aminoacids: Chemistry, Biology and Medicine 1990, p651. Escom Science Publishers, Amsterdam. G. Lubec, G.A. Rosenthal (Eds.).
30. Rockenstein E., Torrance M., Mante M., Adame A., Paulino A., Rose J.B., Crews L., Moessler H., Masliah E. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. J. Neurosci. Res. 2006, 83:1252-1261.
31. Ruether E., Ritter R., Apecechea M., Freytag S., Windisch M. Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT). Pharmacopsychiatry 1994, 27:32-40.
32. Ruether E., Ritter R., Apecechea M., Freytag S., Gmeinbauer R., Windisch M. Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy. J. Neural Transm. 2000, 107:815-829.
33. Sugita Y., Kondo T., Kanazawa A., Itou T., Mizuno Y. Protective effect of FPF 1070 (cerebrolysin) on delayed neuronal death in the gerbil-detection of hydroxyl radicals with salicylic acid. No To Shinkei 1993, 45:325-331.
34. Ubhi K., Rockenstein E., Vazquez-Roque R., Mante M., Inglis C., Patrick C., Adame A., Fahnestock M., Doppler E., Novak P., Moessler H., Masliah E. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease. J. Neurosci. Res. 2013, 91:167-177.
35. Valouskova V., Francis-Turmer L. The short-term influence of b-FGF NGF and Cerebrolysin on the memory impaired after fimbria-fornix lesion. J. Neural Transm. Suppl. 1996, 47:280.
36. Veinbergs I., Mante M., Mallory M., Masliah E. Neurotrophic effects of Cerebrolysin in animal models of excitotoxicity. J. Neural Transm. Suppl. 2000, 59:273-280.
37. 2 in rat neuronal PC12 cells. Nucleic Acids Res. 2000, 28:2135-2140.
38. Windisch M., Piswanger A. Modification of rat brain metabolism by long-term treatment with a peptide derivative. Arzneimittel-Forschung 1985, 35:1353-1356.
39. Wojtowicz J.M., Xiong H., Baskys A. Brain tissue hydrolysate Cerebrolysin, acts on presynaptic adenosine receptors in the rat hippocampus. J. Neural Transm. Suppl. 1996, 47:281.
40. Wyatt A.W., Hussain A., Amann K., Klingel K., Kandolf R., Artunc F., Grahammer F., Huang D.Y., Vallon V., Kuhl D., Lang F. DOCA-induced phosphorylation of glycogen synthase kinase 3beta. Cell. Physiol. Biochem. 2006, 17:137-144.
41. Xiong H., Wojtowicz J.M., Baskys A. Brain tissue hydrolysate acts on presynaptic adenosine receptors in the rat hippocampus. Can. J. Physiol. Pharmacol. 1995, 73:1194-1197.
42. Young A.P., Gunning P.W., Landreth G.E., Ignatius M., Shooter E.M. The nerve growth factor induced differentiation of a pheochromocytoma PC12 cell line. Birth Defects Orig. Artic. Ser. 1983, 19:33-46.
43. Zhang L., Chopp M., Meier D.H., Winter S., Wang L., Szalad A., Lu M., Wei M., Cui Y., Zhang Z.G. Sonic hedgehog signaling pathway mediates Cerebrolysin-improved neurological function after stroke. Stroke 2013, 44:1965-1972.
44. Zhang Y., Chopp M., Meng Y., Zhang Z.G., Doppler E., Mahmood A., Xiong Y. Improvement in functional recovery with administration of Cerebrolysin after experimental closed head injury. J. Neurosurg. 2013, 118:1343-1355.
45. Zhong X., Lin R., Li Z., Mao J., Chen L. Effects of salidroside on cobalt chloride-induced hypoxia damage and mTOR signaling repression in PC12 Cells. Biol. Pharm. Bull. 2014, 37:1199-1206.
46. Zou W., Yan M., Xu W., Huo H., Sun L., Zheng Z., Liu X. Cobalt chloride induces PC12 cells apoptosis through reactive oxygen species and accompanied by AP-1 activation. J. Neurosci. Res. 2001, 64:646-653.
47. Zou W., Zeng J., Zhuo M., Zu W., Sun L., Wang J., Liu X. Involvement of caspase-3 and p38 mitogen-activated protein kinase in cobalt chloride-induced apoptosis in PC12 cells. J. Neurosci. Res. 2002, 67:837-843.